Combination of Locoregional Therapy (LRT) And Tyrosine Kinase Inhibitors (TKIS) is superior to LRT alone in improving the overall survival in Hepatocellular Carcinoma.

Subjects

Subjects :

*PROTEIN-tyrosine kinase inhibitors
*HEPATOCELLULAR carcinoma
*OVERALL survival

Details

Language :

English

ISSN :

09736883

Volume :

13

Database :

Academic Search Index

Journal :

Journal of Clinical & Experimental Hepatology

Publication Type :

Academic Journal

Accession number :

166106669

Full Text :

https://doi.org/10.1016/j.jceh.2023.07.271